Assessment of Knowledge and Concern of People Living with HIV Regarding Human Mpox and Vaccination


Cite item

Full Text

Abstract

Introduction:Mpox virus is an orthopoxvirus that causes the zoonotic infectious disease known as mpox. The disease can also spread from humans to humans. It can be transmitted through contact with bodily fluids, lesions on the skin, or internal mucosal surfaces.

Method:The number of mpox cases increased during the COVID-19 pandemic. Early diagnosis and prompt management of mpox are critical in people living with HIV (PLHIV). In this study, a cross-sectional survey was conducted among PLHIV followed at the outpatient clinic between 20 April–20 August 2023. A questionnaire was used to assess the knowledge and anxiety levels of patients as well as their opinions about vaccination against mpox. The severity of symptoms in the past two weeks was assessed using the Generalised Anxiety Disorder 7-item scale. A total of 203 PLHIV were interviewed for this survey study.

Result:The mean age was 39.37±11.93. The majority of them were male (86.7%), and 41.4% were men who have sex with men (MSM). Only 21 of the surveyed participants (10.4%) had a "good knowledge" score about mpox. The mean knowledge score on human Mpox was 2.05 (min:0-max:8), and 107 (52.7%) had a score of 0.

Conclusion:The future study should focus on continuous education, promoting awareness through programs and establishing measures to successfully overcome identified variables that contribute to mpox pandemic understanding and attitudes. Applying the lessons learned from the COVID-19 pandemic will help the management of mpox virus.

About the authors

Deniz Borcak

Department of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital

Author for correspondence.
Email: info@benthamscience.net

Yusuf Özdemir

Department of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital

Email: info@benthamscience.net

Zuhal Yesilbag

Department of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital

Email: info@benthamscience.net

Esra Ensaroğlu

Department of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital

Email: info@benthamscience.net

Samiha Akkaya

Department of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital

Email: info@benthamscience.net

Kadriye Yaşar

Department of Infectious Diseases and Clinical Microbiology,, Bakırköy Dr. Sadi Konuk Training and Research Hospital

Email: info@benthamscience.net

References

  1. Saavedra OB, Figueroa LDA, Madariaga MES, et al. Antiviral treatment against monkeypox: A scoping review. Trop Med Infect Dis 2022; 7(11): 369. doi: 10.3390/tropicalmed7110369 PMID: 36355910
  2. Sohn EJ. Functional analysis of monkeypox and interrelationship between monkeypox and COVID-19 by bioinformatic analysis. Genet Res 2023; 2023: 1-11. doi: 10.1155/2023/8511036 PMID: 37006463
  3. Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: Infection biology, epidemiology, and evolution. Viruses 2020; 12(11): 1257. doi: 10.3390/v12111257 PMID: 33167496
  4. Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun 2022; 131: 102855. doi: 10.1016/j.jaut.2022.102855 PMID: 35760647
  5. Pinto P, Costa MA, Gonçalves MFM, Rodrigues AG, Lisboa C. Mpox person-to-person transmission—where have we got so far? a systematic review. Viruses 2023; 15(5): 1074. doi: 10.3390/v15051074 PMID: 37243160
  6. Nolasco S, Vitale F, Geremia A, et al. First case of monkeypox virus, SARS-CoV-2 and HIV co-infection. J Infect 2023; 86(1): e21-3. doi: 10.1016/j.jinf.2022.08.014 PMID: 35995308
  7. Derin O, Öztürk EN, Demirbaş ND, Sevgi DY, Dökmetaş İ. A patient presented with genital eruptions: The second case of monkeypox from türkiye. Mikrobiyol Bul 2023; 57(1): 134-40. doi: 10.5578/mb.20239911 PMID: 36636852
  8. Mpox outbreak global map. 2022. Available from: https://www.cdc.gov/poxvirus/mpox/response/2022/world-map.html
  9. Saldana CS, Kelley CF, Aldred BM, Cantos VD. Mpox and HIV: A narrative review. Curr HIV/AIDS Rep 2023; 20(4): 261-9. doi: 10.1007/s11904-023-00661-1 PMID: 37178205
  10. Elsayed S, Bondy L, Hanage WP. Monkeypox virus infections in humans. Clin Microbiol Rev 2022; 35(4): e00092-22. doi: 10.1128/cmr.00092-22 PMID: 36374082
  11. Reynolds M, McCollum A, Nguete B, Lushima SR, Petersen B. Improving the care and treatment of monkeypox patients in low-resource settings: Applying evidence from contemporary biomedical and smallpox biodefense research. Viruses 2017; 9(12): 380. doi: 10.3390/v9120380 PMID: 29231870
  12. Eustaquio PC, Salmon-Trejo LAT, McGuire LC, Ellington SR. Epidemiologic and clinical features of mpox in adults aged >50 years - United States, May 2022-May 2023. MMWR Morb Mortal Wkly Rep 2022; 72(33): 893-6.
  13. Matusali G, Petruccioli E, Cimini E, et al. Evaluation of cross-immunity to the mpox virus due to historic smallpox vaccination. Vaccines 2023; 11(10): 1541.
  14. Turpin RE, Mandell CJ, Camp AD, et al. Monkeypox-related stigma and vaccine challenges as a barrier to HIV pre-exposure prophylaxis among black sexual minority men. Int J Environ Res Public Health 2023; 20(14): 6324. doi: 10.3390/ijerph20146324 PMID: 37510557
  15. Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: A global case series. Lancet 2023; 401(10380): 939-49. doi: 10.1016/S0140-6736(23)00273-8 PMID: 36828001
  16. Curran KG, Eberly K. HIV and sexually transmitted infections among persons with monkeypox - eight U.S. Jurisdictions, May 17-July 22, 2022. MMWR Morb Mortal Wkly Rep 2022; 71(36): 1141-7.
  17. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166(10): 1092-7. doi: 10.1001/archinte.166.10.1092 PMID: 16717171
  18. Gallè F, Bianco L, Da Molin G, et al. "Monkeypox: What do you know about that?" italian adults’ awareness of a new epidemic. Pathogens 2022; 11(11): 1285. doi: 10.3390/pathogens11111285 PMID: 36365036
  19. Peptan C, Băleanu VD, Mărcău FC. Study on the vaccination of the population of romania against monkeypox in terms of medical security. Vaccines 2022; 10(11): 1834. doi: 10.3390/vaccines10111834 PMID: 36366343
  20. Aljamaan F, Alenezi S, Alhasan K, et al. Healthcare workers’ worries and monkeypox vaccine advocacy during the first month of the WHO monkeypox alert: Cross-sectional survey in Saudi Arabia. Vaccines 2022; 10(9): 1408. doi: 10.3390/vaccines10091408 PMID: 36146486
  21. Hong J, Pan B, Jiang HJ, et al. The willingness of Chinese healthcare workers to receive monkeypox vaccine and its independent predictors: A cross-sectional survey. J Med Virol 2023; 95(1): e28294. doi: 10.1002/jmv.28294 PMID: 36367155
  22. Mahameed H, Al-Mahzoum K, AlRaie LA, et al. Previous vaccination history and psychological factors as significant predictors of willingness to receive mpox vaccination and a favorable attitude towards compulsory vaccination. Vaccines 2023; 11(5): 897. doi: 10.3390/vaccines11050897 PMID: 37243001
  23. Majid U, Ahmad M, Zain S, Akande A, Ikhlaq F. COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature. Health Promot Int 2022; 37(3): daac078. doi: 10.1093/heapro/daac078 PMID: 35788306
  24. Ştefănuţ AM, Vintilă M, Tomiţă M, Treglia E, Lungu MA, Tomassoni R. The influence of health beliefs, of resources, of vaccination history, and of health anxiety on intention to accept covid-19 vaccination. Front Psychol 2021; 12: 729803. doi: 10.3389/fpsyg.2021.729803 PMID: 34594282
  25. Swed S, Bohsas H, Alibrahim H, et al. Monkeypox post-COVID-19: Knowledge, worrying, and vaccine adoption in the arabic general population. Vaccines 2023; 11(4): 759. doi: 10.3390/vaccines11040759 PMID: 37112671
  26. Sallam M, Al-Mahzoum K, Dardas LA, et al. Knowledge of human monkeypox and its relation to conspiracy beliefs among students in jordanian health schools: Filling the knowledge gap on emerging zoonotic viruses. Medicina 2022; 58(7): 924. doi: 10.3390/medicina58070924 PMID: 35888642
  27. Camara A, Sow MS, Touré A, et al. Anxiety and depression among HIV patients of the infectious disease department of Conakry University Hospital in 2018. Epidemiol Infect 2020; 148: e8.
  28. Beer L, Tie Y, Padilla M, Shouse RL. Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States. AIDS 2019; 33(11): 1781-7. doi: 10.1097/QAD.0000000000002286 PMID: 31211718
  29. Nyongesa MK, Mwangi P, Koot HM, Cuijpers P, Newton CRJC, Abubakar A. The reliability, validity and factorial structure of the Swahili version of the 7-item generalized anxiety disorder scale (GAD-7) among adults living with HIV from Kilifi, Kenya. Ann Gen Psychiatry 2020; 19(1): 62. doi: 10.1186/s12991-020-00312-4 PMID: 33133222
  30. Ahmed SK, Mohamed MG, Dabou EA, et al. Monkeypox (mpox) in immunosuppressed patients. F1000 Res 2023; 12: 127. doi: 10.12688/f1000research.130272.2 PMID: 37089133
  31. Knight J, Tan DHS, Mishra S. Maximizing the impact of limited vaccine supply under different early epidemic conditions: a 2-city modelling analysis of monkeypox virus transmission among men who have sex with men. CMAJ 2022; 194(46): E1560-7. doi: 10.1503/cmaj.221232 PMID: 36442881
  32. O’Shea J, Filardo TD, Morris SB, Weiser J, Petersen B, Brooks JT. Interim guidance for prevention and treatment of monkeypox in persons with HIV infection — United States, August 2022. MMWR Morb Mortal Wkly Rep 2022; 71(32): 1023-8. doi: 10.15585/mmwr.mm7132e4 PMID: 35951495
  33. Shin MB, Sloan KE, Martinez B, et al. Examining multilevel influences on parental HPV vaccine hesitancy among multiethnic communities in Los Angeles: A qualitative analysis. BMC Public Health 2023; 23(1): 545. doi: 10.1186/s12889-023-15318-2 PMID: 36949438
  34. Rachiotis G, Mouchtouri VA, Kremastinou J, Gourgoulianis K, Hadjichristodoulou C. Low acceptance of vaccination against the 2009 pandemic influenza A(H1N1) among healthcare workers in Greece. Euro Surveill 2010; 15(6): 19486. doi: 10.2807/ese.15.06.19486-en PMID: 20158980
  35. Temsah MH, Aljamaan F, Alenezi S, et al. Monkeypox caused less worry than COVID-19 among the general population during the first month of the WHO Monkeypox alert: Experience from Saudi Arabia. Travel Med Infect Dis 2022; 49: 102426. doi: 10.1016/j.tmaid.2022.102426 PMID: 35963555
  36. Sahin TK, Erul E, Aksun MS, Sonmezer MC, Unal S, Akova M. Knowledge and attitudes of turkish physicians towards human mpox disease and related vaccination: A cross-sectional study. Vaccines 2022; 11(1): 19.
  37. Svartstein ASW, Knudsen AD, Heidari SL, et al. Mpox incidence and vaccine uptake in men who have sex with men and are living with HIV in Denmark. Vaccines 2023; 11(7): 1167. doi: 10.3390/vaccines11071167 PMID: 37514983
  38. Ghaffar RA, Shahnoor S, Farooq M. Increased prevalence of HIV among Monkeypox patients – An alarming update. New Microbes New Infect 2022; 49-50: 101039. doi: 10.1016/j.nmni.2022.101039 PMID: 36284774
  39. Antinori S, Casalini G, Giacomelli A, Morales RAJ. Update on Mpox: A brief narrative review. Infez Med 2023; 31(3): 269-76. PMID: 37701385
  40. Hamdana AH, Mohsin H, Tharwani HZ, et al. Monkeypox virus and other emerging outbreaks: An overview and future perspective. Inquiry 2023; 60(69580231175437) doi: 10.1177/00469580231175437 PMID: 37190997
  41. Al-Sanafi M, Sallam M. Psychological determinants of COVID-19 vaccine acceptance among healthcare workers in Kuwait: A cross-sectional study using the 5c and vaccine conspiracy beliefs scales. Vaccines 2021; 9(7): 701. doi: 10.3390/vaccines9070701 PMID: 34202298

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers